Modulation of NCX1 expression in monocytes associates with multiple sclerosis progression

Area of Science:

• Immunology
• Neuroscience
• Cell Biology

Background:

• Ionic imbalance and monocyte heterogeneity are critical in multiple sclerosis (MS) pathogenesis.
• The sodium-calcium exchanger NCX1's role in monocyte-specific expression during MS is largely unknown.
• Understanding monocyte ionic dysregulation offers insights into MS disease mechanisms and potential treatments.

Purpose of the Study:

• To investigate the expression profile of NCX1 in monocytes during different stages of MS.
• To explore the correlation between NCX1 levels and regulatory T cell (Treg) function in MS patients.
• To identify potential ionic biomarkers and therapeutic targets for MS.

Main Methods:

• Real-time PCR (RT-PCR) for gene expression analysis.
• Flow cytometry and confocal microscopy for protein expression and localization.
• Analysis of NCX1 expression in monocytes from relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS) patients.

Main Results:

• NCX1 expression was significantly upregulated in monocytes of transitional RRMS patients.
• NCX1 expression was significantly reduced in all monocyte subsets after conversion to SPMS.
• Monocyte NCX1 levels correlated with regulatory T cell (Treg) percentage and growth, and associated with altered expression of Ca2+-ATPase, Na+/K+-ATPase, and lncRNA SLC8A1-AS1.

Conclusions:

• A stage-specific dysregulation of NCX1 occurs in monocytes during MS progression.
• Ionic imbalance in monocytes may affect their function and the immune regulatory network in MS.
• These findings highlight NCX1 as a potential biomarker and therapeutic target for MS.